Does CEMIPLIMAB-RWLC Cause Disease progression? 101 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Disease progression have been filed in association with CEMIPLIMAB-RWLC. This represents 6.5% of all adverse event reports for CEMIPLIMAB-RWLC.
101
Reports of Disease progression with CEMIPLIMAB-RWLC
6.5%
of all CEMIPLIMAB-RWLC reports
29
Deaths
15
Hospitalizations
How Dangerous Is Disease progression From CEMIPLIMAB-RWLC?
Of the 101 reports, 29 (28.7%) resulted in death, 15 (14.9%) required hospitalization, and 3 (3.0%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEMIPLIMAB-RWLC. However, 101 reports have been filed with the FAERS database.
What Other Side Effects Does CEMIPLIMAB-RWLC Cause?
Death (128)
Fatigue (71)
Off label use (68)
Rash (64)
Dyspnoea (55)
Pyrexia (52)
Pruritus (44)
Asthenia (42)
Diarrhoea (42)
Myocarditis (42)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which CEMIPLIMAB-RWLC Alternatives Have Lower Disease progression Risk?
CEMIPLIMAB-RWLC vs CENEGERMIN-BKBJ
CEMIPLIMAB-RWLC vs CENOBAMATE
CEMIPLIMAB-RWLC vs CEPHALEXIN
CEMIPLIMAB-RWLC vs CERITINIB
CEMIPLIMAB-RWLC vs CERLIPONASE ALFA